Smith+Nephew Archives - Page 3 of 6 - Medical Design Sourcing

Smith+Nephew introduces a reverse hybrid construct for total knee arthroplasty

Smith+Nephew (NYSE:SNN) announced this week that it launched its Journey II Rox total knee solution, a reverse hybrid construct for total knee arthroplasty.

The company designed the orthopedic device to give surgeons the clinical advantage of advanced bearing material and anatomic design combined with the efficiency and potential long-term tibia fixation of cementless knees.

Journey II Rox has several combinations of S+N’s high-performance technologies in one construct, including the characteristics kinematics of Journey II TKA, the clinical history of Conceloc Advanced Porous Titanium and the wear resistance of Oxinium Oxidized Zirconium. The total knee system is compatible with Smith+Nephew’s Cori surgical robotic system.

“The reverse hybrid combination provides my patients with a powerful collection of knee arthroplasty technologies. The kinematic functionality of Journey II, the biocompatibility and longevity benefits of an oxidized zirco…

Smith+Nephew announces first clinical use of Legion revision knee handheld robotics tech

The Cori surgical robot system for knee replacement. [Image from Smith+Nephew]Smith+Nephew (NYSE:SNN) today announced the first cases for revision knee replacement using the Cori surgical robot system.

Dr. Thorsten Seyler of Duke University performed the first cases on Aug. 17, 2022. Seyler used the combination of Smith+Nephew’s handheld Cori robotic technology with the Legion revision knee system. The system uses image-free smart mapping to eliminate the need for pre-operative CT/MRI scans. It also eliminates the potential for image distortion due to in situ components from the primary procedure.

London-based Smith+Nephew said in a news release that surgeons can build patient-specific 3D models of the joint. They can also register anatomy and bony defects after implant extraction. With the system, surgeons can intra-operatively gap balance in real-time, and accurately precision mill for final placement of components.

Smith+Nephew said it is the first…

Smith+Nephew uses simulation technologies to boost its medical education

Smith+Nephew (NYSE:SNN) announced today that it is expanding its medical education curriculum with advanced simulation technologies.

London-based Smith+Nephew offers new training through its academy center of excellence. Professionals can access orthopedic, robotics and sports medicine procedural skills-training using virtual and augmented reality, haptics and 3D interactive gaming.

Stephen Mitchell is a consultant trauma & orthopedic surgeon at University Hospitals Bristol NHS Foundation Trust. He recently led a hip fracture management course for Smith+Nephew using VR.

“There is a huge opportunity with virtual reality for future training applications to drive both an accelerated learning process and distance training,” Mitchell said in a news release. “It lends itself perfectly to the 2D/3D nature of trauma, arthroscopy and arthroplasty procedures.”

A popular method for medical education

The British medtech giant’s move sugg…

Smith+Nephew announces positive data in Regeneten bioinductive implant study

The Regeneten bioinductive implant [Image from Smith+Nephew]Smith+Nephew (NYSE:SNN) announced today that data supports the use of its Regeneten bioinductive implant in rotator cuff repair.

London-based Smith+Nephew designed Regeneten to provide a patient-centric treatment supporting the body’s natural healing process. The aim is for the implant to change the course of tear progression, aid return to normal activity and reduce re-tears compared to conventional surgery.

Interim analysis from a randomized controlled trial showed a significant reduction in the re-tear rate of full-thickness rotator cuff repairs when using Regeneten, according to a news release. Re-tear rates of patients with medium to large full-thickness tears were measured following either an arthroscopic supraspinatus transosseous equivalent (TOE) repair alone, or the same TOE repair with the addition of a Regeneten implant.

Dr. Miguel Angel Ruiz-Ibán of Hospital Universitario Ramon Y …

16 surgical robotics companies you need to know

Intuitive remains the dominant surgical robotics company, but corporations ranging from Medtronic to Vicarious Surgical look to compete. The Da Vinci Xi robotic surgery system. Intuitive continues to dominate the space. [Image courtesy of Intuitive]Robotic-assisted surgery remains one of the hottest spaces in medtech. Intuitive, which pioneered the field in the 1990s and early 2000s, continues to innovate. At the same time, a host of other companies are looking to compete.

Companies making headlines in the robotic surgery space over the past year include:

Company Robotic system(s) Intuitive Surgical Da Vinci Xi, Da Vinci X, Da Vinci SP, Ion Medtronic Hugo Johnson & Johnson Monarch, Velys, Ottava Stryker Mako Siemens Healthineers’ Corindus CorPath GRX Vicarious Surgical Beta 2 Titan Medical Enos Asensus Surgical Senhance Moon Surgical Maestro Momentus Surgical Anovo Virtual Incision MIRA Stereotaxis Genesis RMN, Vdrive, Niobe Monteris …

The 10 largest orthopedic device companies in the world

Stryker, Johnson & Johnson’s DePuy Synthes and Zimmer Biomet top the list of largest orthopedic device companies. [Adobe Stock image]With elective procedure numbers rebounded after the darkest days of the COVID-19 pandemic, most of the world’s largest orthopedic device companies saw their revenues increase by double-digit percentages during their most recent fiscal years.

Here are the world’s 10 largest orthopedic device companies, ranked by ortho business revenue pulled from their most recent annual reports:

Largest orthopedic device companies Annual revenue (% change) Headquarters 1 Stryker $17.1 billion (+19.2%) Kalamazoo, Michigan 2 Johnson & Johnson – DePuy Synthes $8.6 billion (+10.6%) Locations: Raynham, Massachusetts.; West Chester, Pennsylvania; Warsaw, Indiana; Palm Beach Gardens, Florida 3 Zimmer Biomet (minus ZimVie spinoff) $6.8 billion (+11.6%) Warsaw, Indiana 4 Medtronic – Cranial & Spinal Technologies $4.5 billion (+3.9%) Locat…

Smith+Nephew stock dives on Q2 results, lowered 2022 trading margin guidance

Smith+Nephew (NYSE:SNN) shares took a hit today as the company revealed in its second-quarter earnings that it lowered its 2022 forecast.

SNN shares were down 11.3% at $26.04 per share in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1.1%.

For the six-month period ended June 30 reported by the London-based company, Smith+Nephew posted profits of $242 million, or 20¢ per share, on sales of $2.6 billion for a 1.3% bottom-line gain as sales totals remained effectively the same.

Adjusted to exclude one-time items, earnings per share were 38¢.

Revenues for the second quarter — the only metric reported for the three-month period by Smith+Nephew — came in at $1.3 billion, representing a year-over-year sales decline of 3.1%.

“Our focus is on delivering our transformational strategy,” Smith+Nephew CEO Deepak Nath said in a news release. &…

The biggest medtech personnel moves so far in 2022

In the ever-changing world of medtech, those who are leading the companies are bound to move around a bit.

At the end of last year, we compiled a list of medtech’s biggest personnel changes in 2021. Throughout just over half of 2022, we’ve already seen a slew of major moves around some of the space’s most powerful players.

Here is a list of some of the biggest personnel changes in medtech so far in 2022:

3M’s healthcare president retires 3M Health Care Business Group President Mojdeh Poul [Image courtesy of 3M]Mojdeh Poul, the president of 3M’s healthcare business, announced in May that she would retire from the position and her retirement was made effective on July 1.

Poul joined 3M in 2011 as the global business VP of critical and chronic care solutions. She later became VP and general manager of the company’s food safety business and president of numerous 3M divisions, including infection prevention, 3M Canada, and sa…

Smith+Nephew partners with Rods&Cones on smart surgery glasses

[Image from Smith+Nephew/Rods&Cones]Smith+Nephew (NYSE:SNN) announced today that it partnered with Rods&Cones to provide smart surgery glasses and digital remote assistance.

London-based Smith+Nephew representatives, by providing customers with smart surgery glasses, can “see” through the eyes of the surgeon, instrumentalist nurse or any healthcare professional using them, offering continuous remote support before, during and after surgical interventions.

The offering was initially used in the United Kingdom to support the National Health Service (NHS) and other customers. Smith+Nephew plans to increase its ability to offer technical support for the safe and effective use of its products at the right time from anywhere in the world.

Smith+Nephew said the increased complexity of surgery, the advancement of technologies and the need for productivity and efficiency is enabled by ensuring a specialist is available remotely to give the best p…

Smith+Nephew opens new plant in Malaysia

Officials in Penang, Malaysia say the state has become a medtech hub in the region [Image courtesy of Google]Smith+Nephew recently opened a 250,000-square-foot advanced manufacturing facility in Malaysia.

Representing a more than $100 million investment, the plant will primarily support the British medtech giant’s orthopedics business, which the company expects to grow strongly in the Asia-Pacific region.

S+N expects the facility — located at the Batu Kawan Industrial Park in Malaysia’s northwest state of Penang — to create 800 local jobs in manufacturing, engineering and supply chain in the coming years.

“We are thrilled to open this new manufacturing facility in Malaysia which represents our commitment to Asia-Pacific, Malaysia, our customers and their patients. It is also a critical piece of our Strategy for Growth, improving efficiency and resilience, and supports our purpose of Life Unlimited so that patients across the region and beyond ca…

Smith+Nephew is moving out of its historic U.K. home

The location of Hull, U.K., Smith+Nephew’s historic home [Image courtesy of Google]Smith+Nephew (LSE:SN, NYSE:SNN) announced today that it will build a new R&D and manufacturing facility for its Advanced Wound Management franchise that will move the company outside of its historic home of Hull.

S+N started in 1856 in Hull. The new R&D and manufacturing hub will be at the Melton West business park — about 8 miles from the present location, where the company has had a location for more than 100 years.

Smith+Nephew will invest more than $100 million in the new facility, with support from a U.K. government grant. The development will also be supported by a grant from UK Government. After its expected opening in 2024, the new facility is expected to support more than $10 billion in sales during its first 10 years of operation.

“This major investment demonstrates our commitment to the U.K. and to building our leadership in Advanced Wound Manag…

Smith+Nephew rises on Q4 earnings, announces new CEO

Smith+Nephew (NYSE:SNN) shares ticked up today as it announced a new CEO along with its quarterly earnings.

Shares of SNN were up 6.4% at $34.67 per share in late-afternoon trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was up 1%.

The company confirmed that Dr. Deepak Nath will succeed Roland Diggelmann in the role of CEO after Diggelmann steps down, a move that will be made as a result of a mutual agreement.

Nath will begin as CEO on April 1, 2022, after Diggelmann departs on March 31, 2022, according to a news release.

“It has been a privilege to lead Smith+Nephew,” Diggelmann said in the release. “I would like to thank my colleagues across the business for their tireless efforts to support our customers and communities, and continue to deliver against the backdrop of COVID. I look forward to seeing the business go from strength to strength under Dee…